Neuberger Berman Group LLC Amgen Inc Transaction History

Neuberger Berman Group LLC

$118 Billion
Q2 2024

A detailed history of Neuberger Berman Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Neuberger Berman Group LLC holds 199,168 shares of AMGN stock, worth $64.3 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

199,168

Previous 401,629 50.41%

Holding current value

$64.3 Million

Previous $114 Million 45.5%

% of portfolio

0.05%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $53.2 Million - $64.6 Million	-202,461 Reduced 50.41%	199,168 $62.2 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $108 Million - $130 Million	401,629 New	401,629 $114 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $137 Million - $154 Million	535,356 Added 400.84%	668,915 $193 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $84.6 Million - $105 Million	-386,698 Reduced 74.33%	133,559 $35.9 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $1.21 Million - $1.43 Million	-5,641 Reduced 1.07%	520,257 $116 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $90.1 Million - $110 Million	399,074 Added 314.67%	525,898 $127 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $1.3 Million - $1.65 Million	-5,678 Reduced 4.29%	126,824 $33.3 Million
Q3 2022 Nov 15, 2022	BUY	$224.46 - $253.15 $5.73 Million - $6.46 Million	25,506 Added 23.84%	132,502 $29.9 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $1.45 Million - $1.61 Million	6,274 Added 6.23%	106,996 $26.1 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $796,607 - $881,256	3,633 Added 3.74%	100,722 $22.9 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $6.4 Million - $7.32 Million	-32,166 Reduced 24.89%	97,089 $20.6 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $4.19 Million - $4.91 Million	-19,742 Reduced 13.25%	129,255 $27 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $1.58 Million - $1.75 Million	6,748 Added 4.74%	148,997 $35.7 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $1.79 Million - $2.09 Million	-8,084 Reduced 5.38%	142,249 $34.9 Million
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $3.12 Million - $3.71 Million	-14,409 Reduced 8.75%	150,333 $34.4 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $564,098 - $627,323	-2,404 Reduced 1.44%	164,742 $41.9 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $1.97 Million - $2.42 Million	-9,972 Reduced 5.63%	167,146 $39.4 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $1.16 Million - $1.54 Million	-6,364 Reduced 3.47%	177,118 $35.9 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $1.11 Million - $1.43 Million	-5,881 Reduced 3.11%	183,482 $44.2 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $311,308 - $373,012	1,788 Added 0.95%	189,363 $36.6 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $1.22 Million - $1.43 Million	-7,317 Reduced 3.75%	187,575 $34.6 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $3.45 Million - $3.89 Million	19,076 Added 10.85%	194,892 $37 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $3.75 Million - $4.38 Million	21,033 Added 13.59%	175,816 $34.2 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $1.08 Million - $1.22 Million	5,836 Added 3.92%	154,783 $32.1 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $170,201 - $191,172	1,025 Added 0.69%	148,947 $27.6 Million
Q1 2018 May 08, 2018	SELL	$169.43 - $198.0 $5.95 Million - $6.95 Million	-35,097 Reduced 19.18%	147,922 $25.3 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $2.85 Million - $3.18 Million	-16,867 Reduced 8.44%	183,019 $32 Million
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $33.4 Million - $38.2 Million	199,886	199,886 $37.3 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Amgen Inc Transaction History